Close

Botulinum Toxin Injections to the "11s" Between the Brows Produce Significant Patient Satisfaction Rates According to FACE-Q Survey

Study in the Aesthetic Surgery Journal Highlights Patient-Perceived Benefits

June 28, 2016 11:32 AM EDT

NEW YORK, June 28, 2016 /PRNewswire-USNewswire/ -- Botulinum toxin type A injections are the most common cosmetic procedure performed in the United States, with 4.3 million procedures performed in 2015 accounting for 42% of all cosmetic procedures in that year, based on the Cosmetic Surgery National Data Bank Statistics from the American Society for Aesthetic Plastic Surgery, (ASAPS). According to a new study published in the Aesthetic Surgery Journal, the official publication of ASAPS, patient satisfaction with their overall facial appearance increased by 28% with injections to the so-called "11s" (the glabellar rhytids which are the lines that appear between the brows as we age). The satisfaction rate was determined based on participating patients' completion of the FACE-Q survey, a newly developed and validated patient-reported outcome instrument that can be used for measuring patient's own perceptions of cosmetic facial procedures. The survey consists of 63 questions asking patients to evaluate their overall appearance, age appearance, and the appearance of cheeks, nasolabial folds, lower face and jawline, chin and neck.

Dr. Daniel C. Mills, President of ASAPS states, "The results of this study are not surprising and validate what we've suspected for quite some time. I see an ever-increasing influx of patients in my practice in Laguna Beach, CA requesting botulinum toxin type A injections to the area between the brows and other areas on the face like the crow's feet and forehead as a preventative anti-aging or, pre-aging measure from patients in their 20s up to their 70s. It's a quick nonsurgical fix that packs a powerful punch and this new study reaffirms the efficacy of botulinum toxin type A and the satisfaction it brings to patients," he explains.

The study's authors examined 57 female patients who completed the FACE-Q survey. After the baseline survey, the patients received injections of one brand of botulinum toxin type A, (Botox, Dysport or Xeomin) in the region between the brows. Two weeks post-injection, the patients completed the FACE-Q survey again. The percentage changes in patient responses from the first to second surveys were assessed to determine how the injections affected patient satisfaction with their facial appearance.

Patients stated that they believe they look an average of 5.6 years younger post-injection with any of the botulinum toxin type A products, (Botox, Dysport and Xeomin). The average age of the 57 patients with pre- and post-neurotoxin FACE-Q responses was 49.6 years (range of 32 – 75 years old).

Table 3. Post-Neuromodulation Change in Satisfaction with Facial Appearance Overall

Facial Appearance Aspect

Average Percentage Change

P-Value

Symmetry

+38.0%

0.002

Balance

+12.3%

0.001

Proportion

+6.3%

0.054

Appearance at the End of Day

+30.8%

Freshness

+36.3%

Restfulness

+46.5%

Profile Appearance

+23.5%

0.001

Appearance in Photos

+28.7%

Appearance when Waking Up

+22.8%

0.001

Appearance under Bright Lights

+23.2%

0.002

Rasch Transformed Score

+27.7%

*Average percentage change, pre- to post-neuromodulation, in the questions and overall Rasch score for the satisfaction with facial appearance overall section.

"This indicates that patients' satisfaction with their overall facial appearance was statistically significantly greater after receiving the injections, and certainly accounts for the continued success of neurotoxin popularity to reduce the signs of aging," states Dr. Ivona Percec, the study's senior author.

To view the complete study, visit the Aesthetic Surgery Journal site.

About the Aesthetic Surgery Journal

Aesthetic Surgery Journal is a peer-reviewed international journal focusing on scientific developments and clinical techniques in aesthetic surgery. An official publication of the American Society for Aesthetic Plastic Surgery (ASAPS), ASJ is also the official English-language journal of many major international societies of plastic, aesthetic and reconstructive surgery representing South America, Central America, Europe, Asia, and the Middle East. It is also the official journal of Canadian Society for Aesthetic Plastic Surgery and The Rhinoplasty Society.

ASJ was indexed with MEDLINE/PubMed in 2008 and covered by the Thomson Reuters' Journal Citation Report since 2011. ASJ's current Impact Factor is 2.502. In the 2015 JCR, ASJ ranked 53rd out of 199 journals in the overall surgery category. ASJ is presently ranked #1 among all aesthetic surgery journals and #2 among all plastic surgery journals.

About ASAPS

The American Society for Aesthetic Plastic Surgery (ASAPS), is recognized as the world's leading organization devoted entirely to aesthetic plastic surgery and cosmetic medicine of the face and body.  ASAPS is comprised of over 2,600 Plastic Surgeons; Active Members are certified by the American Board of Plastic Surgery (USA) or by the Royal College of Physicians and Surgeons of Canada and have extensive training in the complete spectrum of surgical and non-surgical aesthetic procedures. International Active Members are certified by equivalent boards of their respective countries. All members worldwide adhere to a strict Code of Ethics and must meet stringent membership requirements.

Website: www.surgery.orgFollow ASAPS on Twitter: www.twitter.com/ASAPSBecome a fan of ASAPS on Facebook: www.facebook.com/AestheticSocietyJoin Smart Beauty Guide: www.smartbeautyguide.comLocate a plastic surgeon in your area: http://www.smartbeautyguide.com/select-surgeon

Logo - http://photos.prnewswire.com/prnh/20140226/DC72077LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/botulinum-toxin-injections-to-the-11s-between-the-brows-produce-significant-patient-satisfaction-rates-according-to-face-q-survey-300291362.html

SOURCE American Society for Aesthetic Plastic Surgery



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Twitter